Anti-I17RB/ IL17RB/ CRL4 monoclonal antibody

Anti-I17RB/ IL17RB/ CRL4 antibody for FACS & in-vivo assay

Target products collectionGo to IL17RB/IL17RB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-TA074-Ab-1/ GM-Tg-hg-TA074-Ab-2Anti-Human IL17RB monoclonal antibodyHuman
GM-Tg-rg-TA074-Ab-1/ GM-Tg-rg-TA074-Ab-2Anti-Rat IL17RB monoclonal antibodyRat
GM-Tg-mg-TA074-Ab-1/ GM-Tg-mg-TA074-Ab-2Anti-Mouse IL17RB monoclonal antibodyMouse
GM-Tg-cynog-TA074-Ab-1/ GM-Tg-cynog-TA074-Ab-2Anti-Cynomolgus/ Rhesus macaque IL17RB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-TA074-Ab-1/ GM-Tg-felg-TA074-Ab-2Anti-Feline IL17RB monoclonal antibodyFeline
GM-Tg-cang-TA074-Ab-1/ GM-Tg-cang-TA074-Ab-2Anti-Canine IL17RB monoclonal antibodyCanine
GM-Tg-bovg-TA074-Ab-1/ GM-Tg-bovg-TA074-Ab-2Anti-Bovine IL17RB monoclonal antibodyBovine
GM-Tg-equg-TA074-Ab-1/ GM-Tg-equg-TA074-Ab-2Anti-Equine IL17RB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-TA074-Ab-1/ GM-Tg-hg-TA074-Ab-2; GM-Tg-rg-TA074-Ab-1/ GM-Tg-rg-TA074-Ab-2;
GM-Tg-mg-TA074-Ab-1/ GM-Tg-mg-TA074-Ab-2; GM-Tg-cynog-TA074-Ab-1/ GM-Tg-cynog-TA074-Ab-2;
GM-Tg-felg-TA074-Ab-1/ GM-Tg-felg-TA074-Ab-2; GM-Tg-cang-TA074-Ab-1/ GM-Tg-cang-TA074-Ab-2;
GM-Tg-bovg-TA074-Ab-1/ GM-Tg-bovg-TA074-Ab-2; GM-Tg-equg-TA074-Ab-1/ GM-Tg-equg-TA074-Ab-2
Products NameAnti-IL17RB monoclonal antibody
Formatmab
Target NameIL17RB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL17RB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species I17RB/ IL17RB/ CRL4 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-TA074-Ag-1interleukin 17 receptor B (IL17RB) protein
    ORF Viral VectorvGMLP001667human IL17RB Lentivirus particle
    ORF Viral VectorpGMLP001667human IL17RB Lentivirus plasmid


    Target information

    Target IDGM-TA074
    Target NameIL17RB
    Gene ID55540,50905,306247,693671,476587,101080437,533605,100059421
    Gene Symbol and SynonymsCRL4,EVI27,IL-17ER,IL-17Rh1,IL17BR,IL17RB,IL17RH1
    Uniprot AccessionQ9NRM6
    Uniprot Entry NameI17RB_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000056736
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IL17RB, gene name: IL17RB, also named as CRL4, EVI27, IL17BR, IL17RH1. The protein encoded by this gene is a cytokine receptor. This receptor specifically binds to IL17B and IL17E, but does not bind to IL17 and IL17C. This receptor has been shown to mediate the activation of NF-kappaB and the production of IL8 induced by IL17E. The expression of the rat counterpart of this gene was found to be significantly up-regulated during intestinal inflammation, which suggested the immunoregulatory activity of this receptor. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.